Guogan Wang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of the study was to evaluate the efficacy and safety of 1-h infusion of recombinant human atrial natriuretic peptide (rhANP) in combination with standard therapy in patients with acute decom-pensated heart failure (ADHF). This was a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Eligible patients with ADHF were(More)
  • 1